Am J Perinatol 2009; 26(8): 565-573
DOI: 10.1055/s-0029-1220775
© Thieme Medical Publishers

Zygomycosis in Neonates: An Uncommon but Life-threatening Infection

Emmanuel Roilides1 , 4 , Theoklis E. Zaoutis2 , Aspasia Katragkou1 , Daniel K. Benjamin3 , Thomas J. Walsh4
  • 13rd Department of Pediatrics, Aristotle University, Thessaloniki, Greece
  • 2Department of Pediatrics and the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, and Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
  • 3Department of Pediatrics, Duke Clinical Research Institute, Duke University, Durham, North Carolina
  • 4Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland
Further Information

Publication History

Publication Date:
23 April 2009 (online)

Preview

ABSTRACT

We systematically reviewed all published cases of zygomycosis, an increasingly important infection with high mortality, in neonates. We searched PubMed and individual references for English publications of single cases or case series of neonatal (0 to 1 month) zygomycosis. Cases were included if they fulfilled prespecified criteria. Fifty-nine cases were published through July 2007. Most of the infants (77%) were premature. The most common sites of zygomycosis were gastrointestinal (54%) and cutaneous (36%) diseases. This pattern differs from sinopulmonary and rhinocerebral patterns of older children. Fifty-six percent of cases were diagnosed by histology only and 44% by histology and culture. Rhizopus spp. were isolated from 18/25 (72%) cases. Thirty-seven percent of patients received no antifungal therapy. Thirty-two (54%) neonates underwent surgery with (39%) or without (15%) antifungal agents. Overall mortality was 64%. A higher fraction of neonates treated with amphotericin B and surgery survived than those who received no therapy (70% versus 5%). Zygomycosis is a life-threatening infection in neonates with a distinct pattern of gastrointestinal and cutaneous involvement and high mortality. Combination of amphotericin B and surgery was common management strategy in survivors.

REFERENCES

Emmanuel RoilidesM.D. Ph.D. 

3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital

Konstantinoupoleos 49, GR-546 42 Thessaloniki, Greece

Email: roilides@med.auth.gr